Gastric bypass surgery has become a relatively low-risk bariatric surgical intervention in a high-risk patient population (Nguyen et al., Arch Surg, 141:445–449,
2006; Buchwald et al. JAMA, 13:1724–1737,
2004). Surgical interventions in patients suffering from morbid obesity are typically associated with excess morbidity (Parikh et al., Am Surg, 73:959–962,
2007). Though overall mortality after bariatric surgery is <1% is low (Mason et al., Obes Surg, 17:9–14,
2007), some surgical complications such as anastomotic leaks, staple line disruption and bowel obstruction may still impact on postoperative outcome (Parikh et al., Am Surg, 73:959–962,
2007; Mason et al., Obes Surg, 17:9–14,
2007). Early symptoms are often missed, as clinical presentation may be discreet, inexistent or falsely attributed to obesity.